Form 10-Q · Quarterly report
Solventum 10-Q, filed Nov 5, 2026
- Filed
- CIK
- 0001964738
- Accession no.
- 0001964738-26-000056
Summary
Solventum reported third-quarter 2026 net sales of $1.949 billion, down 7.0% from a year earlier and 2.8% on an organic basis, and said it is evaluating a range of separation pathways for its Health Information Systems business after announcing on August 5, 2026 its intention to pursue a separation. Solventum also recovered $118 million of roughly $120 million in IEEPA tariff refunds accepted by U.S. Customs and Border Protection, following the U.S. Supreme Court's February 20, 2026 decision that IEEPA does not authorize the President to impose tariffs.
Key points
- Third-quarter 2026 sales fell 7.0% reported and 2.8% organically, with U.S. organic sales down 4.2%, after customers reduced inventory following about $125 million of advanced ordering in the second quarter tied to a July 2026 U.S. ERP deployment.
- Total company operating income was $68 million in the third quarter of 2026, compared with $1,690 million a year earlier.
- Solventum recovered $118 million of the approximately $120 million in IEEPA tariff refunds that U.S. Customs and Border Protection accepted in June 2026, as of September 30, 2026.
- Solventum completed the sale of its Purification and Filtration business to Thermo Fisher Scientific on September 1, 2025 for cash consideration of approximately $4 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview Solventum is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise. Our 70+ year history of discovering and innovating advanced solutions has helped us solve our customers’ toughest challenges and become a trusted partner. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.